Company profile · free preview
Colgate-Palmolive
CL · Updated 11/13/2026
Revenue
$20.4B
Fiscal 2025
Net income
$2.1B
Fiscal 2025
Free cash flow
—
Fiscal 2025
Net cash / (debt)
—
Fiscal 2025
Five-year financials
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $20.4B | $20.1B | $19.5B | $18.0B | $17.4B |
| Net income | $2.1B | $2.9B | $2.3B | $1.8B | $2.2B |
| Diluted EPS | — | — | — | — | — |
| Operating cash flow | $4.2B | $4.1B | $3.7B | $2.6B | $3.3B |
| Free cash flow | — | — | — | $1.9B | $2.8B |
| Cash | $1.3B | $1.1B | $966.0M | $775.0M | $832.0M |
| Total debt | — | — | — | — | — |
Financial trends
Historical · FY2021–FY2025
Source: Reported annual filings (10-K / 20-F) and provider data. Fiscal years as reported; margins are calculated from the reported figures shown.
Want the story behind these numbers? Ask Osiris anything about Colgate-Palmolive's filings — free.
Create free accountWhere the cash went
Cumulative, fiscal 2021–2025, straight from the reported cash-flow statements.
Reinvested in capex
—
of operating cash flow
Returned to owners
—
of free cash flow (buybacks + dividends)
Diluted share count
—
change 2021–2025
| Operating cash flow | $17.9B |
| Capital expenditure | — |
| Free cash flow | — |
| Share buybacks | — |
| Dividends paid | — |
| Acquisitions (net) | — |
| Net debt issued / (repaid) | — |
| Stock-based compensation (non-cash) | — |
"—" means a year didn't report that line, so no total is shown rather than an estimate.
Colgate-Palmolive return on capital (fiscal 2025)
ROIC
25.7%
Return on capital
24.5%
Return on equity
1603.0%
Return on assets
13.2%
Gross margin
60.1%
Operating margin
20.8%
Net debt / EBITDA
1.70x
Colgate-Palmolive insider buying and selling
Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-11-05 | NORRINGTON LORRIE M | Sale | 4,170 | $99.31 |
| 2026-11-05 | Wallace Noel R. | Sale | 20,000 | $100.26 |
| 2026-11-04 | Hazlin John | Sale | 23,376 | $99.15 |
| 2026-11-04 | Tsourapas Panagiotis | Sale | 19,938 | $98.74 |
SEC filings
No filings stored yet.
Ask anything about Colgate-Palmolive's filings
"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.
Start researching free